2Thorley-Lawson DA, Nadler LM, Bhan AK, et al.BLAST-2 [ EBVCS], an early cell surface marker of human Bcell activation, is superinduced by Epsstein Barr virus[J]. J Immunol, 1985, 134:3007-3012.
3Huissoon AP, Emery P, Bacon PA, et al. Increased expression of CD23 in rhematoid synovitis[J ]. Scand J Rheumatol, 2000, 29 : 154-159.
4刘恭值，许化溪，章谷生，等．现代医学免疫学[M]．南京：江苏科学技术出版社，2000．135．
5Ribben C, Bonnet V, Kaiser M J, et al. Increased synoveal fluid levels of soluble CD23 are associated sith an drosive status in rheumatiod arthritis (RA) [ J 1.Clinical Clin Exp lmmunol, 2000, 120: 194-199.
6Descamps Latscha B, Herbelin A, Nguyen AT, et al.Soluble CD23 as an effector of immune dysregulation in chronic uremia and dialysis[J]. Kidney lnt, 1993,43:878-884.
7Beaurain G, Naret, Marcon L, et al. In vivo T cell activation In chronic uremic hemodialyzed and nonhemodialyzed patients[ J ]. Kidney Int, 1989, 36 : 636-644.
8Rezzonico R, Chicheportiche R, Imbert V, et al. Engagement of CDllb and CD1 lc beta 2 integrin by antibodies or soluble CD23 induces IL-1 beta production on primary human monocytes through mitogen-activated protein kinase-dependent pathways[J ]. Blood, 2000,95:3868-3877.
9Daniel EF. The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis[J]. Seminars in Arthritis and Rheumatism,2010,39(5) : 327-346.
10Mira M,Stijn V,Luc SDC,et al. Central Sensitization in Patients with Rheumatoid Arthritis:A Systematic Literature Review[J]. Seminars in Arthritis and Rheumatism, 2012,41 (4) : 556-567.
